Glycosidase Inhibitors

Application Used in the first enantioselective synthesis of ( R )- and ( S )-4-acetyl-3-(hydroxymethyl)-3,4-dihydro-2 H -pyrido[3,2- b ]oxazines. Legal Information Manufactured under license by Sterling Pharma Solutions Limited, using Jacobsen HKR

Other Notes Important D -glucopyranose derivative for glucosylations and other reactions Preparation of the &#945-glucopyranosyl chloride Synthesis of 1-C-&#945- D -glucopyranose derivatives

Other Notes Important D -glucopyranose derivative for glucosylations and other reactions Preparation of the &#945-glucopyranosyl chloride Synthesis of 1-C-&#945- D -glucopyranose derivatives

Biochem/physiol Actions For reactions with complex carbohydrates, the substrate must be labeled with aminonaphthalenetrisulfonic acid (ANTS). Unit Definition One unit will release 1.

Anti-AGER advanced glycosylation end product-specific recept

Anti-AGER advanced glycosylation end product-specific recept

Glucosylceramidase (EC 3.2.

Anti-GBA glucosidase, beta, acid, 100ul UN 1687 6.1 PG2

Anti-GBA glucosidase, beta, acid, 25ul UN 1687 6.1 PG2

A potent, selective, reversible, and competitive non-peptide inhibitor of cathepsin G (IC 50 = 53 nM and K i = 63 nM). Weakly inhibits chymotrypsin (K i = 1.

A potent, selective, reversible, and competitive non-peptide inhibitor of cathepsin G (IC 50 = 53 nM and K i = 63 nM). Weakly inhibits chymotrypsin (K i = 1.

A cell-permeable glycinyl hydrazone compound that acts as a potent, selective and reversible open-channel blocker of CFTR with intermediate speed (&lt1 min 95% inhibition at 50 &#181M K i = 4.3 &#181M in CFTR-expressing FRT cells for apical